Safex Chemicals IPO

Safex Chemicals (India) IPO Details

Safex Chemicals (India) IPO is a 100% book-built issue, comprising a fresh issue of ₹450 crore and an offer for sale (OFS) of 3.57 crore equity shares, with a face value of ₹1 per share. The company filed its DRHP on July 3, 2025.

The price band and official dates of subscription and listing will be announced by the company later, but the shares are supposed to be listed on the BSE and the NSE platforms. The book-running lead managers of this issue are Axis Capital Ltd., JM Financial Ltd. and SBI Capital Markets Ltd., while the registrar to the issue is KFin Technologies Ltd.

Safex Chemicals (India) IPO Date & Timeline

Safex Chemicals (India) Ltd. officially filed its Draft Red Herring Prospectus (DRHP) on July 3, 2025. However, the specific Safex Chemicals (India) IPO date and subscription timeline remain unannounced. Following regulatory approval, the company will finalise the price band and bidding dates. Once cleared, the schedule for anchor allotment, public bidding and the final listing on the exchange will be formally disclosed.

Safex Chemicals (India) IPO GMP (Grey Market Premium)

“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.

The Safex Chemicals (India) IPO GMP is currently trading at ₹[.], reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹[.], which is [.]% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.

Company Background

Safex Chemicals (India) was incorporated in January 1991 in New Delhi. Over 30 years, the company has grown from branded agrochemical formulations into a diversified speciality chemicals entity. It has expanded through organic growth and strategic acquisitions, including Shogun Organics in 2021 and UK-based Briar Chemicals in 2022.

The company is engaged in the chemical industry, focusing on agrochemicals with a different business model. They operate in 3 different verticals, catering to the needs of farmers and mainly aim to help increase crop productivity by providing a wide range of crop protection products. Currently, Safex operates as an integrated player with a footprint spanning 22 countries across six continents.

Operations & Product Range

Safex Chemicals (India) Ltd. operates through three key business verticals: Branded Formulations, Speciality Chemicals, and CDMO. The vertical of Branded Formulations boasts 140 different products that range from insecticides, herbicides, fungicides, to plant growth regulators. The speciality chemical segment comprises products in technical grade forms as opposed to formulations. On the other hand, the CDMO vertical entails contract manufacturing for agrochemical majors such as Bayer AG.

Facilities & Capacity

Safex Chemicals (India) Ltd. operates 8 specialised manufacturing facilities, of which 7 are located within India's agrochemical hubs in Bahadurgarh (Haryana), Una (Himachal Pradesh) and Pune (Maharashtra) and the 8th is a 115-acre campus in Norwich, United Kingdom, serving as the hub for international CDMO operations. These facilities are supported by quality control and process safety operations and a dedicated workforce of over 1,500 full-time employees as of March 2025.

Brands & Market Presence

Safex Chemicals (India) Ltd. has built a formidable market presence through a unique multi-brand strategy utilizing brands such as Safex, IndoSwiss and Smith N Smith to cater to different market segments. Domestic presence is supported by a pan-India distribution network of over 14,950 active dealers. Internationally, nearly 29% of FY25 revenue was derived from overseas markets across 22 countries. Its proprietary mosquito repellent molecule, "Renofluthrin" has further enhanced its brand reputation as an innovator in the household insecticide space.

Revenue Streams & Business Model

The primary revenue channel of Safex Chemicals (India) Ltd. is generated through branded formulations, technical ingredients and specialised CDMO service contracts. In FY25, branded formulations accounted for 62.47% of consolidated revenue, the CDMO segment contributed 27.01% and speciality chemicals approximately 17.30% (before inter-segment eliminations). This diversified revenue mix mitigates seasonal risks inherent in the agrochemical industry, while backward integration into technical manufacturing provides control over raw material quality and costs.

Management & Shareholding

Safex Chemicals (India) Ltd. is promoted by Neeraj Kumar Jindal, Piyush Jindal, Rajesh Kumar Jindal and Surinder Kumar Chaudhary. Before the IPO, the promoter held 37.97% and the promoter group held 16.33%; together, they held the 54.30% stake in the company, but after the IPO, the promoters and promoter group will face a minor dilution as the offering consists of 3.57 crore OFS by existing shareholders.

Board & Key Management

The leadership of Safex Chemicals (India) Ltd. is led by a team of experts with many years of experience. Surinder Kumar Chaudhary serves as the Chairman and gives strategic direction to the firm. The daily operations are managed by Neeraj Kumar Jindal, the Managing Director. To ensure good governance, the board includes Independent Directors Prem Chand, Yogesh Kapur, Savan Rashmikant Godiawala, Bipinchandra Solanki and Manisha Raghunath Kadagathur for honest oversight. Together, this team uses its knowledge to help the company grow and stay successful.